|
|
|
Insider
Information: |
Ajer Jeffrey Robert |
Relationship: |
Director |
City: |
Novato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
100,920 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,960,592 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
100,920 |
|
|
Total
Value |
$5,960,592 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-61.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-05-02 |
66,767 |
|
0 |
Premium* |
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2024-03-15 |
4 |
D |
$83.87 |
$1,893,785 |
D/D |
(22,580) |
71,467 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial OfOffice |
|
2012-09-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,570 |
|
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2012-11-28 |
4 |
OE |
$14.39 |
$106,110 |
D/D |
5,916 |
16,486 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-01-22 |
4 |
OE |
$21.51 |
$64,530 |
D/D |
3,000 |
13,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-03-04 |
4 |
OE |
$21.51 |
$86,040 |
D/D |
4,000 |
14,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-04-19 |
4 |
OE |
$21.51 |
$107,550 |
D/D |
5,000 |
15,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-12-09 |
4 |
OE |
$14.39 |
$253,183 |
D/D |
13,026 |
27,906 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2014-03-06 |
4 |
OE |
$21.51 |
$473,165 |
D/D |
17,370 |
42,750 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2014-12-03 |
4 |
OE |
$38.59 |
$463,080 |
D/D |
12,000 |
43,590 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-05-06 |
4 |
OE |
$21.51 |
$1,141,215 |
D/D |
33,631 |
76,664 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-07-20 |
4 |
OE |
$63.10 |
$189,300 |
D/D |
3,000 |
38,605 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-05-05 |
4 |
OE |
$28.23 |
$162,879 |
D/D |
4,486 |
55,030 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-09-22 |
4 |
OE |
$37.46 |
$131,897 |
D/D |
3,521 |
50,110 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-11-14 |
4 |
OE |
$63.10 |
$567,900 |
D/D |
9,000 |
58,135 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2020-06-19 |
4 |
OE |
$63.10 |
$946,500 |
D/D |
15,000 |
78,402 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2023-01-25 |
4 |
OE |
$67.81 |
$3,322,690 |
D/D |
49,000 |
90,088 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2012-11-12 |
4 |
S |
$48.11 |
$12,750 |
D/D |
(265) |
10,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2012-11-28 |
4 |
S |
$48.31 |
$285,817 |
D/D |
(5,916) |
10,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-12-09 |
4 |
S |
$69.55 |
$906,010 |
D/D |
(13,026) |
14,880 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2014-12-03 |
4 |
S |
$91.01 |
$1,092,161 |
D/D |
(12,000) |
31,590 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-05-06 |
4 |
S |
$119.14 |
$4,053,042 |
D/D |
(34,019) |
42,645 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2021-09-22 |
4 |
S |
$17.78 |
$65,164 |
D/D |
(3,665) |
32,510 |
0 |
% |
|
NKTR |
Nektar Therapeutics |
Director |
|
2022-09-23 |
4 |
S |
$3.16 |
$13,266 |
D/D |
(4,198) |
38,512 |
0 |
% |
|
NKTR |
Nektar Therapeutics |
Director |
|
2023-09-18 |
4 |
S |
$0.69 |
$3,008 |
D/D |
(4,359) |
34,153 |
0 |
% |
|
174 Records found
|
|
Page 7 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|